Table 3

Prevalence of anti-CCP antibodies and RF in the serum of patients enrolled in this study

Variable

RA (n = 30)

HCV without articular involvement (n = 31)

HCV with articular involvement (n = 8)

Anti-CCP, no. (%)

23 (76.6)

0 (0)

0 (0)

RF, no. (%)

27 (90)

3 (9.7)

3 (37.5)

Anti-CCP, anti-cyclic citrullinated peptide; HCV, hepatitis C virus; RA, rheumatoid arthritis; RF, rheumatoid factor.

Bombardieri et al. Arthritis Res Ther 2004 6:R137   doi:10.1186/ar1041